This pre-specified cardiovascular meta-analysis included all seven randomized controlled trials with a duration of at least 26 weeks from the tirzepatide T2D clinical development program, SURPASS

Typical presentation includes: Localized redness: A circular or irregular area of pink to red discoloration, usually 1-3 cm in diameter, centered around the injection point Swelling: Mild elevation of the skin with a firm or slightly boggy texture, reflecting subcutaneous fluid accumulation and inflammation Tenderness: Discomfort ranging from mild sensitivity to moderate pain when the area is touched or pressed Pruritus: Itching sensation that may be mild to moderate, occasionally accompanied by a desire to scratch Warmth: The affected area may feel slightly warmer than surrounding skin due to increased blood flow Less commonly, patients may notice small bruises (ecchymoses) or minor bleeding at the injection site, particularly if a small blood vessel was inadvertently punctured during injection
Curcumin analogues and their hybrid molecules as multifunctional drugs
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 1289 million children, adolescents, and adults (in Eng)